Stock Events

Acadia Pharmaceuticals (ACAD) Q4 2014 Earnings

10NovConfirmed
Q1 2014
Q2 2014
Q3 2014
Q4 2014
-0.25
-0.21
-0.17
-0.13

Details

Expected EPS
-0.22
Actual EPS
-0.25
Surprise EPS
-0.03
Surprise Percent
+13.64%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.25 per share for Q4 2014.

0 Comments

Share your thoughts